文献速递临床试验与 GCP流行病学与生物统计

静脉性腿部溃疡的加压治疗:VenUS 6 随机临床试验

Compression therapies for venous leg ulcers: The VENous Ulcer Study 6 (VenUS 6), an open, multicentre, randomised clinical trial.
PubMed 文献 · PLoS Med · 2026-07-10

VenUS 6 是一项英国多中心三臂随机试验,637 名静脉性腿部溃疡成人随机接受加压缠绕、两层绷带或循证加压(两层弹力袜或四层绷带)。主要结局为盲法评估的溃疡愈合时间。两层绷带对循证加压达到非劣效(HR 1.01,95%CI 0.79–1.28),加压缠绕愈合慢于循证加压(HR 0.78,95%CI 0.61–1.00;p=0.046)。

要点

  • 两层绷带对循证加压在溃疡愈合时间上达到预设非劣效界值 1.33(HR 1.01)。
  • 加压缠绕愈合速度慢于循证加压(HR 0.78,p=0.046),不优于两层绷带。
  • 结果统计不确定性大,且治疗偏离常见,影响外推。

核心结论

  • 加压缠绕相比两层绷带或循证加压不太可能缩短静脉性腿部溃疡愈合时间。
  • 两层绷带对循证加压达到非劣效,但假设策略分析未显示非劣效。
  • 结果可能不支持将加压缠绕作为一线强效加压治疗。

研究设计与样本

  • 实用型三臂随机对照试验,在英国 33 个初级、社区和医院站点开展,2021 年 2 月 3 日至 2024 年 8 月 31 日。
  • 637 名适合加压治疗的静脉性腿部溃疡成人按 1:1:1 随机分配至加压缠绕(n=213)、两层绷带(n=211)或循证加压(n=213)。
  • 参与者与临床人员未设盲,主要结局为盲法评估的溃疡愈合时间,633 人纳入分析。
  • 试验预注册号 ISRCTN67321719。

主要发现

  • 平均年龄 70.3 岁(范围 24.6–97.0),55%(n=351)为男性,95%(n=606)为白人。
  • 治疗策略策略下,两层绷带对循证加压非劣效比较的 HR 为 1.01(95%CI 0.79–1.28),达到预设非劣效界值 1.33。
  • 假设策略分析 HR 为 1.16(95%CI 0.86–1.58),未证明非劣效。
  • 加压缠绕组愈合慢于循证加压组(HR 0.78,95%CI 0.61–1.00;p=0.046)。
  • 加压缠绕组对两层绷带组 HR 为 0.79(95%CI 0.61–1.01;p=0.056)。

关键数值与推荐

  • 非劣效界值为 1.33。
  • 两层绷带对循证加压 HR 1.01(95%CI 0.79–1.28)。
  • 加压缠绕对循证加压 HR 0.78(95%CI 0.61–1.00;p=0.046)。
  • 加压缠绕对两层绷带 HR 0.79(95%CI 0.61–1.01;p=0.056)。

临床怎么用

  • 两层绷带可作为循证加压的替代选择用于静脉性腿部溃疡加压治疗。
  • 加压缠绕不宜作为静脉性腿部溃疡的一线强效加压治疗。
  • 选择加压方案时需考虑治疗偏离对实际效果的影响。

局限性

  • 对分配治疗的偏离常见,限制结果在不同依从性模式环境中的推广。
  • 溃疡愈合发生率低于预期及轻微招募不足,导致愈合事件数少于 80% 把握度所需。
  • 参与者和临床人员未设盲。
  • 发生 9 例严重不良事件,其中 1 例可能与治疗相关(死因无法确定)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Strong compression is a recommended first line venous leg ulcer treatment. With limited research comparing the clinical effectiveness of compression wraps (CW) and two-layer compression bandage treatments with evidence-based compression (EBC) (four-layer compression bandages and two-layer compression hosiery), this study aimed to evaluate their clinical effectiveness on time to venous leg ulcer healing. METHODS AND FINDINGS: A pragmatic, three-arm, randomised controlled trial in 33 United Kingdom primary, community and hospital sites between 03.02.2021 and 31.08.2024. Adults with a venous leg ulcer appropriate for compression therapy were randomised 1:1:1 to be offered CW, two-layer bandage, or EBC (two-layer hosiery or four-layer bandage). Participants and clinical staff were not blinded. The primary outcome was time to blind assessed ulcer healing (date of ulcer healing: date of earliest photograph showing healing). Analyses included a noninferiority comparison of two-layer bandage and EBC (handling key intercurrent events under hypothetical and treatment policy strategies), and superiority comparisons of CW with both EBC and two-layer bandage (handling key intercurrent events under a treatment policy strategy). Healing times were analysed using Cox proportional hazards regression adjusted for fixed effects (treatment allocation, baseline ulcer area and duration, participant age, and mobility status), and shared frailties (recruitment site). The trial was pre-registered: ISRCTN67321719. 637 participants were randomised to be offered CW (n = 213), two-layer bandage (n = 211) or EBC (n = 213). Mean age was 70.3 (range 24.6 to 97.0) years, 55% (n = 351) were male, and the majority (n = 606, 95%) were white. 633 participants contributed time at risk of healing and were included in the analysis. Using a treatment policy strategy to handle key intercurrent events (modified intention-to-treat analysis), the estimated hazard ratio (HR) for the noninferiority comparison (EBC and two-layer bandage) was 1.01 (95% CI [0.79, 1.28]), meeting the pre-specified noninferiority margin of 1.33. The corresponding hypothetical strategy analysis gave a HR of 1.16 (95% CI [0.86, 1.58]), which did not demonstrate noninferiority. For the superiority comparisons, healing was slower in the CW group than in the EBC group (HR 0.78, 95% CI [0.61, 1.00]; p = 0.046). Results were similar for the two-layer bandage group (HR 0.79, 95% CI [0.61, 1.01]; p = 0.056), although this did not reach statistical significance. Both comparisons showed considerable statistical uncertainty, with confidence intervals ranging from a 39% reduction in the hazard of healing to little or no difference between groups. Nine serious adverse events occurred; one potentially related to treatment (cause of death could not be ascertained). Departures from allocated compression treatment were common, which limits generalisability to settings with different adherence patterns. These departures, lower than expected ulcer healing incidence rates and slight under-recruitment, resulted in the number of healing events being smaller than the number required for 80% power. CONCLUSION: CW is unlikely to reduce the time to venous leg ulcer healing compared to two-layer bandage or EBC, although confidence intervals included treatment effects indicating little or no difference between groups. Despite remaining uncertainty, these findings may not support CW as a first line strong compression treatment for venous leg ulcers. TRIAL REGISTRATION: ISRCTN - reference 67321719.

来源:PLoS Med,查看原文。版权归原作者所有。

引用

  1. Arundel C, Welch C, Strachan L, et al. Compression therapies for venous leg ulcers: The VENous Ulcer Study 6 (VenUS 6), an open, multicentre, randomised clinical trial. PLoS Med. 2026. PMID: 42430377. doi:10.1371/journal.pmed.1005154

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。